Table 2.

Examples of EDCs and Their Possible Mechanisms Resulting in Clinical Conditions. (4)(9)(10)

EDCsMain SourcesPossible MechanismClinical condition
AlkylphenolsDetergents Shampoos
Pesticide
Mimics estrogenBreast cancer
PhthalatesPlastic products
Personal care products (perfume, moisturizer)
Not yet knownTesticular and ovarian toxicants
Polychlorinated biphenyls
(chlorinated/ halogenated/
TBBPA)
Paints
Plastics
Lubricants
Electrical applications
Estrogenic and anti-androgenic activity
Indirectly regulate circulating gonadal hormones.
Inducers of CYP1A and CYPIIB
Decreased NMDA receptor binding in striatum, frontal cortex and hippocampus, cerebellum
Reduced glutamate and dopamine
Acts at AhR signaling pathways resulting in cytotoxic effects
Neurobehavioral defects like cognitive deficits in children
Neurotoxicity
Thyroid toxicity
Susceptibility to infections
Cancers (especially Breast Cancer)
Infertility

TBBPA- Tetrabromobisphenol A, CYP - cytochrome P450 enzymes, NMDA- N-methyl-D-aspartate, AhR - aryl hydrocarbon receptor

From: Endocrine Disruptor Chemicals

Cover of Endotext
Endotext [Internet].
Feingold KR, Anawalt B, Blackman MR, et al., editors.
South Dartmouth (MA): MDText.com, Inc.; 2000-.
Copyright © 2000-2024, MDText.com, Inc.

This electronic version has been made freely available under a Creative Commons (CC-BY-NC-ND) license. A copy of the license can be viewed at http://creativecommons.org/licenses/by-nc-nd/2.0/.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.